Table 4 Relative risk of abnormal serum biomarkers MoMs of AFP, b-hCG, uE3 and IHA between non-SGA vs SGA group
Group | Non-SGA Group (n: 9577) | SGA Group (n: 578) | P-value | Relative risk (95%CI) |
|---|---|---|---|---|
AFP > 2 MoMs | 355 (85.1%) | 62 (14.9%) | <  0.001 | 2.81 (2.20–3.58) |
AFP < 2 MoMs | 9222 (94.7%) | 516 (5.3%) | ||
b-hCG > 2 MoMs | 321 (85.4%) | 55 (14.6%) | <  0.001 | 2.74 (2.11–3.54) |
b-hCG < 2 MoMs | 9256 (94.7%) | 523 (5.3%) | ||
uE3 <  0.5 MoMs | 316 (90.8%) | 32 (9.2%) | 0.004 | 1.65 (1.17–2.32) |
uE3 > 0.5 MoMs | 9261 (94.4%) | 546 (5.6%) | ||
IHA > 2 MoMs | 253 (88.5%) | 33 (11.5%) | < 0.001 | 2.09 (1.50–2.91) |
IHA < 2 MoMs | 9324 (94.5%) | 545 (5.5%) |